Last updated: 5 March 2024 at 5:06pm EST

Dr. Joseph Monahan Net Worth




The estimated Net Worth of Joseph Monahan is at least $1.51 Million dollars as of 1 March 2024. Dr Monahan owns over 73,425 units of Aclaris Therapeutics Inc stock worth over $224,571 and over the last 3 years he sold ACRS stock worth over $1,280,699.

Dr Monahan ACRS stock SEC Form 4 insiders trading

Dr has made over 16 trades of the Aclaris Therapeutics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 73,425 units of ACRS stock worth $86,642 on 1 March 2024.

The largest trade he's ever made was exercising 87,175 units of Aclaris Therapeutics Inc stock on 1 March 2023 worth over $102,867. On average, Dr trades about 22,840 units every 59 days since 2021. As of 1 March 2024 he still owns at least 190,314 units of Aclaris Therapeutics Inc stock.

You can see the complete history of Dr Monahan stock trades at the bottom of the page.





Dr. Joseph Monahan biography

Dr. Joseph Monahan is the Chief Scientific Officer at Aclaris Therapeutics Inc.



What's Dr Monahan's mailing address?

Joseph's mailing address filed with the SEC is C/O ACLARIS THERAPEUTICS, INC., 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087.

Insiders trading at Aclaris Therapeutics Inc

Over the last 9 years, insiders at Aclaris Therapeutics Inc have traded over $101,608,525 worth of Aclaris Therapeutics Inc stock and bought 10,163,038 units worth $66,383,599 . The most active insiders traders include Braden Michael Leonard, Capital Management, Llc Kol..., and Llc Fmr. On average, Aclaris Therapeutics Inc executives and independent directors trade stock every 17 days with the average trade being worth of $111,818. The most recent stock trade was executed by Kevin Balthaser on 1 September 2024, trading 1,000 units of ACRS stock currently worth $1,180.



What does Aclaris Therapeutics Inc do?

aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.



What does Aclaris Therapeutics Inc's logo look like?

Aclaris Therapeutics Inc logo

Complete history of Dr Monahan stock trades at Aclaris Therapeutics Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
1 Mar 2024 Joseph Monahan
Chief Scientific Officer
Option 73,425 $1.24 $91,047
1 Mar 2024
190,314
1 Feb 2024 Joseph Monahan
Chief Scientific Officer
Option 7,500 $1.20 $9,000
1 Feb 2024
137,224
23 Oct 2023 Joseph Monahan
Chief Scientific Officer
Sale 6,000 $5.08 $30,480
23 Oct 2023
129,724
21 Aug 2023 Joseph Monahan
Chief Scientific Officer
Sale 6,000 $7.32 $43,920
21 Aug 2023
135,724
20 Jun 2023 Joseph Monahan
Chief Scientific Officer
Sale 6,000 $10.28 $61,680
20 Jun 2023
141,724
1 Mar 2023 Joseph Monahan
Chief Scientific Officer
Option 87,175 $12.24 $1,067,022
1 Mar 2023
163,761
15 Feb 2023 Joseph Monahan
Chief Scientific Officer
Sale 5,000 $13.06 $65,300
15 Feb 2023
91,386
15 Dec 2022 Joseph Monahan
Chief Scientific Officer
Sale 5,000 $15.88 $79,400
15 Dec 2022
96,386
17 Oct 2022 Joseph Monahan
Chief Scientific Officer
Sale 5,000 $15.98 $79,900
17 Oct 2022
101,386
18 Apr 2022 Joseph Monahan
Chief Scientific Officer
Sale 30,000 $16.28 $488,400
18 Apr 2022
106,386
10 Mar 2022 Joseph Monahan
Chief Scientific Officer
Sale 27,165 $15.71 $426,762
10 Mar 2022
136,386
1 Mar 2022 Joseph Monahan
Chief Scientific Officer
Option 76,250 $14.94 $1,139,175
1 Mar 2022
163,551
9 Feb 2022 Joseph Monahan
Chief Scientific Officer
Sale 383 $12.68 $4,856
9 Feb 2022
87,301
1 Feb 2022 Joseph Monahan
Chief Scientific Officer
Option 1,050 $11.58 $12,159
1 Feb 2022
87,684
1 Sep 2021 Joseph Monahan
Chief Scientific Officer
Option 2,333 $17.22 $40,174
1 Sep 2021
87,675
1 Jun 2021 Joseph Monahan
Chief Scientific Officer
Option 50,000 $23.64 $1,182,000
1 Jun 2021
107,132


Aclaris Therapeutics Inc executives and stock owners

Aclaris Therapeutics Inc executives and other stock owners filed with the SEC include: